TABLE 2.
Projected Excess Mortality and Morbidity Attributable to Current Adolescent Obesity: United States, 2020–2050
| Mortality, 1 000 Life-Years Lost | Morbidity, 1 000 Life-Years |
||||
| Treatment Setting | CHD | Diabetes Without CHD | Obesity Onlya | Totalb | |
| Without additional treatments (setting 1, base case) | 1480 | 5500 | 9 390 | 146 000 | 161 000 |
| Universal treatment of hypertension and hyperlipidemia (setting 2) | 1190 | 4210 | 9 780 | 148 000 | 162 000 |
| Universal treatment of hypertension and hyperlipidemia, plus lower targets for patients with diabetes with these risk factors (setting 3) | 1090 | 3490 | 10 600 | 148 000 | 162 000 |
| Universal treatment of hypertension and hyperlipidemia, with lower targets for patients with diabetes with these risk factors, plus tight glycemic control for diabetes (setting 4) | 1060 | 3430 | 10 700 | 148 000 | 162 000 |
Note. CHD = cardiovascular disease.
a
Obesity without diabetes or CHD.
b
May not add up because of rounding.